The DOI matches its Crossref record; 140 of the 140 references it cites were found in a registry or an index.
Recent advances in apoptosis, mitochondria and drug resistance in cancer cells
Open accessAbstract
Defective or inefficient apoptosis is an acquired hallmark of cancer cells. Thus, a thorough understanding of apoptotic signaling pathways and insights into apoptosis resistance mechanisms are imperative to unravel novel drug targets for the design of more effective and target selective therapeutic strategies. This review aims at providing an overview of the recent understanding of apoptotic signaling pathways, the main mechanisms by which cancer cells resist apoptotic insults, and discusses some recent attempts to target the mitochondrion for restoring efficient cell death signaling in cancer cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Hirpara, J. L., Clement, M., & Pervaiz, S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m004687200 · Cited by 145
Self-citationRetractedHanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics
Kerr, J. F. R., Wyllie, A. H., & Currie, A. R. (1972) · British Journal of Cancer · doi:10.1038/bjc.1972.33 · Cited by 15,725
Apoptosis: A Review of Programmed Cell Death
Elmore, S. (2007) · Toxicologic Pathology · doi:10.1080/01926230701320337 · Cited by 13,853
Death Receptors: Signaling and Modulation
Ashkenazi, A., & Dixit, V. M. (1998) · Science · doi:10.1126/science.281.5381.1305 · Cited by 5,866
Hengartner, M. O. (2000) · Nature · doi:10.1038/35037710 · Cited by 5,779
The phosphoinositide 3-kinase pathway
Cantley, L. C. (2002) · Science · doi:10.1126/science.296.5573.1655 · Cited by 5,621
Lane, D. P. (1992) · Nature · doi:10.1038/358015a0 · Cited by 5,138
Danial, N. N., & Korsmeyer, S. J. (2004) · Cell · doi:10.1016/s0092-8674(04)00046-7 · Cited by 4,651
The Bcl2 family: regulators of the cellular life-or-death switch
Cory, S., & Adams, J. M. (2002) · Nature Reviews Cancer · doi:10.1038/nrc883 · Cited by 4,032
BCL-2 family members and the mitochondria in apoptosis
Gross, A., McDonnell, J. M., & Korsmeyer, S. J. (1999) · Genes & Development · doi:10.1101/gad.13.15.1899 · Cited by 3,641
Mitochondrial membrane permeabilization in cell death
Kroemer, G., Galluzzi, L., & Brenner, C. (2007) · Physiological Reviews · doi:10.1152/physrev.00013.2006 · Cited by 3,598
Self-citationAn inhibitor of Bcl-2 family proteins induces regression of solid tumours
Oltersdorf, T., Elmore, S. W., Shoemaker, A. R., Armstrong, R. C., Augeri, D. J., Belli, B. A., Bruncko, M., Deckwerth, T. L., Dinges, J., Hajduk, P. J., et al. (2005) · Nature · doi:10.1038/nature03579 · Cited by 3,416
Two CD95 (APO‐1/Fas) signaling pathways
Scaffidi, C., Fulda, S., Srinivasan, A., Friesen, C., Li, F., Tomaselli, K. J., Debatin, K., Krammer, P. H., & Peter, M. E. (1998) · The EMBO Journal · doi:10.1093/emboj/17.6.1675 · Cited by 3,000
Programmed Cell Death in Animal Development
Jacobson, M. D., Weil, M., & Raff, M. C. (1997) · Cell · doi:10.1016/s0092-8674(00)81873-5 · Cited by 2,698
The mitochondrial permeability transition pore and its role in cell death
CROMPTON, M. (1999) · Biochemical Journal · doi:10.1042/bj3410233 · Cited by 2,432
The mitochondrial permeability transition
Zoratti, M., & Szabò, I. (1995) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(95)00003-a · Cited by 2,401
Shimizu, S., Narita, M., Tsujimoto, Y., & Tsujimoto, Y. (1999) · Nature · doi:10.1038/20959 · Cited by 2,178
Noxa, a BH3-Only Member of the Bcl-2 Family and Candidate Mediator of p53-Induced Apoptosis
Oda, E., Ohki, R., Murasawa, H., Nemoto, J., Shibue, T., Yamashita, T., Tokino, T., Taniguchi, T., & Tanaka, †. N. (2000) · Science · doi:10.1126/science.288.5468.1053 · Cited by 2,112
Direct Activation of Bax by p53 Mediates Mitochondrial Membrane Permeabilization and Apoptosis
Chipuk, J. E., Kuwana, T., Bouchier-Hayes, L., Droin, N. M., Newmeyer, D. D., Schuler, M., & Green, D. R. (2004) · Science · doi:10.1126/science.1092734 · Cited by 2,108
Bad, a heterodimeric partner for Bcl-xL and Bcl-2, displaces bax and promotes cell death
Yang, E., Zha, J., Jockel, J., Boise, L. H., Thompson, C. B., & Korsmeyer, S. J. (1995) · Cell · doi:10.1016/0092-8674(95)90411-5 · Cited by 2,100
Slee, E. A., Harte, M. T., Kluck, R. M., Wolf, B. B., Casiano, C. A., Newmeyer, D. D., Wang, H.-G., Reed, J. C., Nicholson, D. W., Alnemri, E. S., et al. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.144.2.281 · Cited by 1,929
Mitochondria as the central control point of apoptosis
Desagher, S., & Martinou, J.-C. (2000) · Trends in Cell Biology · doi:10.1016/s0962-8924(00)01803-1 · Cited by 1,913
Tsujimoto, Y., Finger, L. R., Yunis, J., Nowell, P. C., & Croce, C. M. (1984) · Science · doi:10.1126/science.6093263 · Cited by 1,769
The p66shc adaptor protein controls oxidative stress response and life span in mammals
Migliaccio, E., Giorgio, M., Mele, S., Pelicci, G., Reboldi, P., Pandolfi, P. P., Lanfrancone, L., & Pelicci, P. G. (1999) · Nature · doi:10.1038/46311 · Cited by 1,712
Targeting mitochondria for cancer therapy
Fulda, S., Galluzzi, L., & Kroemer, G. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3137 · Cited by 1,629
Betteridge, D. J. (2000) · Metabolism · doi:10.1016/s0026-0495(00)80077-3 · Cited by 1,455
The reverse Warburg effect: Aerobic glycolysis in cancer associated fibroblasts and the tumor stroma
Pavlides, S., Whitaker-Menezes, D., Castello-Cros, R., Flomenberg, N., Witkiewicz, A. K., Frank, P. G., Casimiro, M. C., Wang, C., Fortina, P., Addya, S., et al. (2009) · Cell Cycle · doi:10.4161/cc.8.23.10238 · Cited by 1,391
Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death
Joza, N., Susin, S. A., Daugas, E., Stanford, W. L., Cho, S. K., Li, C. Y. J., Sasaki, T., Elia, A. J., Cheng, H.-Y. M., Ravagnan, L., et al. (2001) · Nature · doi:10.1038/35069004 · Cited by 1,366
Targeting death and decoy receptors of the tumour-necrosis factor superfamily
Ashkenazi, A. (2002) · Nature Reviews Cancer · doi:10.1038/nrc821 · Cited by 1,360
Activation of Apoptosis in Vivo by a Hydrocarbon-Stapled BH3 Helix
Walensky, L. D., Kung, A. L., Escher, I., Malia, T. J., Barbuto, S., Wright, R. D., Wagner, G., Verdine, G. L., & Korsmeyer, S. J. (2004) · Science · doi:10.1126/science.1099191 · Cited by 1,349
Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization
Zindy, F., Eischen, C. M., Randle, D. H., Kamijo, T., Cleveland, J. L., Sherr, C. J., & Roussel, M. F. (1998) · Genes & Development · doi:10.1101/gad.12.15.2424 · Cited by 1,245
van Delft, M. F., Wei, A. H., Mason, K. D., Vandenberg, C. J., Chen, L., Czabotar, P. E., Willis, S. N., Scott, C. L., Day, C. L., Cory, S., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.08.027 · Cited by 1,240
Kuwana, T., Bouchier-Hayes, L., Chipuk, J. E., Bonzon, C., Sullivan, B. A., Green, D. R., & Newmeyer, D. D. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.02.003 · Cited by 1,185
Bax and Adenine Nucleotide Translocator Cooperate in the Mitochondrial Control of Apoptosis
Marzo, I., Brenner, C., Zamzami, N., Jürgensmeier, J. M., Susin, S. A., Vieira, H. L. A., Prévost, M.-C., Xie, Z., Matsuyama, S., Reed, J. C., et al. (1998) · Science · doi:10.1126/science.281.5385.2027 · Cited by 1,168
Self-citationOncogenic alterations of metabolism
Dang, C. V., & Semenza, G. L. (1999) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(98)01344-9 · Cited by 1,106
Reed, J. C. (1998) · Oncogene · doi:10.1038/sj.onc.1202591 · Cited by 1,049
Konopleva, M., Contractor, R., Tsao, T., Samudio, I., Ruvolo, P. P., Kitada, S., Deng, X., Zhai, D., Shi, Y.-X., Sneed, T., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.10.006 · Cited by 1,023
Dysregulation of Apoptosis in Cancer
Reed, J. C. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.9.2941 · Cited by 987
Facile Detection of Mitochondrial DNA Mutations in Tumors and Bodily Fluids
Fliss, M. S., Usadel, H., Caballero, O. L., Wu, L., Buta, M. R., Eleff, S. M., Jen, J., & Sidransky, D. (2000) · Science · doi:10.1126/science.287.5460.2017 · Cited by 820
Mitochondrial p53 activates Bak and causes disruption of a Bak–Mcl1 complex
Leu, J. I.-J., Dumont, P., Hafey, M., Murphy, M. E., & George, D. L. (2004) · Nature Cell Biology · doi:10.1038/ncb1123 · Cited by 770
The central executioners of apoptosis: caspases or mitochondria?
Green, D., & Kroemer, G. (1998) · Trends in Cell Biology · doi:10.1016/s0962-8924(98)01273-2 · Cited by 766
ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage
Maya, R., Balass, M., Kim, S.-T., Shkedy, D., Leal, J.-F. M., Shifman, O., Moas, M., Buschmann, T., Ronai, Z., Shiloh, Y., et al. (2001) · Genes & Development · doi:10.1101/gad.886901 · Cited by 731 · cited 1×
“Phosphorylation of p53 disrupts p53's interaction with Mdm2 and ushers its activation [32,33].”
BackgroundMetabolic Modulation of Glioblastoma with Dichloroacetate
Michelakis, E. D., Sutendra, G., Dromparis, P., Webster, L., Haromy, A., Niven, E., Maguire, C., Gammer, T.-L., Mackey, J. R., Fulton, D., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3000677 · Cited by 720
Mitochondrial Binding of Hexokinase II Inhibits Bax-induced Cytochrome c Release and Apoptosis
Pastorino, J. G., Shulga, N., & Hoek, J. B. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109950200 · Cited by 713
Tumor Mitochondria and the Bioenergetics of Cancer Cells
Pedersen, P. L. (2015) · Progress in Tumor Research · doi:10.1159/000401202 · Cited by 711
Duckett, C. S., Nava, V. E., Gedrich, R. W., Clem, R. J., Van Dongen, J. L., Gilfillan, M. C., Shiels, H., Hardwick, J. M., & Thompson, C. B. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00629.x · Cited by 633
Bedikian, A. Y., Millward, M., Pehamberger, H., Conry, R., Gore, M., Trefzer, U., Pavlick, A. C., DeConti, R., Hersh, E. M., Hersey, P., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.0483 · Cited by 600
Delocalized lipophilic cations selectively target the mitochondria of carcinoma cells
Modica-Napolitano, J. S., & Aprille, J. R. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00125-9 · Cited by 576
p53 Induces Apoptosis by Caspase Activation through Mitochondrial Cytochrome c Release
Schuler, M., Bossy-Wetzel, E., Goldstein, J. C., Fitzgerald, P., & Green, D. R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.10.7337 · Cited by 560
Madesh, M., & Hajnóczky, G. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200105057 · Cited by 538
Birnbaum, M. J., Clem, R. J., & Miller, L. K. (1994) · Journal of Virology · doi:10.1128/jvi.68.4.2521-2528.1994 · Cited by 536
Ben Sahra, I., Laurent, K., Giuliano, S., Larbret, F., Ponzio, G., Gounon, P., Le Marchand-Brustel, Y., Giorgetti-Peraldi, S., Cormont, M., Bertolotto, C., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2782 · Cited by 536
Murray-Zmijewski, F., Lane, D. P., & Bourdon, J.-C. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401914 · Cited by 523
Halestrap, A., & Brenner, C. (2003) · Current Medicinal Chemistry · doi:10.2174/0929867033457278 · Cited by 503
Self-citationInhibition of Mitochondrial Respiration
Pelicano, H., Feng, L., Zhou, Y., Carew, J. S., Hileman, E. O., Plunkett, W., Keating, M. J., & Huang, P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301546200 · Cited by 495
The Long Form of FLIP Is an Activator of Caspase-8 at the Fas Death-inducing Signaling Complex
Micheau, O., Thome, M., Schneider, P., Holler, N., Tschopp, J., Nicholson, D. W., Briand, C., & Grütter, M. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206882200 · Cited by 482
Transcription-independent pro-apoptotic functions of p53
Moll, U. M., Wolff, S., Speidel, D., & Deppert, W. (2005) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2005.09.007 · Cited by 468
The bioenergetic signature of cancer: a marker of tumor progression.
Cuezva, J. M., Krajewska, M., de Heredia, M. L., Krajewski, S., Santamaría, G., Kim, H., Zapata, J. M., Marusawa, H., Chamorro, M., & Reed, J. C. (2002) · PubMed · Cited by 443
Reactive Oxygen Species in Mitochondria-Mediated Cell Death
Orrenius, S. (2007) · Drug Metabolism Reviews · doi:10.1080/03602530701468516 · Cited by 426
Apoptosis: molecular mechanisms in programmed cell death.
Fésüs, L., Davies, P. J., & Piacentini, M. (1991) · PubMed · Cited by 420
Apoptosis: Programmed cell death at a molecular level
Schultz, D. R., & Harringto, W. J. (2003) · Seminars in Arthritis and Rheumatism · doi:10.1053/sarh.2003.50005 · Cited by 356
APOPTOSIS AND DISEASE: Regulation and Clinical Relevance of Programmed Cell Death
M. Rudin, M., & B. Thompson, M. (1997) · Annual Review of Medicine · doi:10.1146/annurev.med.48.1.267 · Cited by 354
Henze, K., & Martin, W. (2003) · Nature · doi:10.1038/426127a · Cited by 349
Bcl-2 and Bax regulate the channel activity of the mitochondrial adenine nucleotide translocator
Brenner, C., Cadiou, H., Vieira, H. L., Zamzami, N., Marzo, I., Xie, Z., Leber, B., Andrews, D., Duclohier, H., Reed, J. C., et al. (2000) · Oncogene · doi:10.1038/sj.onc.1203298 · Cited by 332
Self-citationRalph, S. J., Rodríguez-Enríquez, S., Neuzil, J., Saavedra, E., & Moreno-Sánchez, R. (2010) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2010.02.008 · Cited by 331
p63 and p73, the ancestors of p53
Dotsch, V., Bernassola, F., Coutandin, D., Candi, E., & Melino, G. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a004887 · Cited by 326
Enhancement of chemotherapy by manipulation of tumour pH
Raghunand, N., He, X., Sluis, R. V., Mahoney, B., Baggett, B., Taylor, C. W., Paine-Murrieta, G., Roe, D., Bhujwalla, Z. M., & Gillies, R. J. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690455 · Cited by 316
Pharmacologic activation of p53 elicits Bax-dependent apoptosis in the absence of transcription
Chipuk, J. E., Maurer, U., Green, D. R., & Schuler, M. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00272-1 · Cited by 299
Coller, H. A., Khrapko, K., Bodyak, N. D., Nekhaeva, E., Herrero-Jimenez, P., & Thilly, W. G. (2001) · Nature Genetics · doi:10.1038/88859 · Cited by 288
The Warburg Effect: Why and How Do Cancer Cells Activate Glycolysis in the Presence of Oxygen?
Lopez-Lazaro, M. (2008) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152008783961932 · Cited by 285
Costantini, P., Belzacq, A.-S., Vieira, H. L., Larochette, N., de Pablo, M. A., Zamzami, N., Susin, S. A., Brenner, C., & Kroemer, G. (2000) · Oncogene · doi:10.1038/sj.onc.1203299 · Cited by 284
Self-citationMITCHELL, P., & MOYLE, J. (1965) · Nature · doi:10.1038/208147a0 · Cited by 278
p63 and p73 in human cancer: defining the network
DeYoung, M. P., & Ellisen, L. W. (2007) · Oncogene · doi:10.1038/sj.onc.1210337 · Cited by 266
Wong, C. H., Iskandar, K. B., Yadav, S. K., Hirpara, J. L., Loh, T., & Pervaiz, S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009996 · Cited by 263
Self-citationMDM2 and MDM4: p53 regulators as targets in anticancer therapy
Toledo, F., & Wahl, G. M. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.03.022 · Cited by 261
ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage
Chen, L., Gilkes, D. M., Pan, Y., Lane, W. S., & Chen, J. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600812 · Cited by 260
Indran, I. R., Hande, M. P., & Pervaiz, S. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-1588 · Cited by 256
Self-citationMitochondria: a hub of redox activities and cellular distress control
Kakkar, P., & Singh, B. K. (2007) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-007-9520-8 · Cited by 255
Apoptosis regulators and their role in tumorigenesis
Zörnig, M., Hueber, A.-O., Baum, W., & Evan, G. (2001) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(01)00031-2 · Cited by 239
The Role of PET Scan in Diagnosis, Staging, and Management of Non-Small Cell Lung Cancer
Schrevens, L., Lorent, N., Dooms, C., & Vansteenkiste, J. (2004) · The Oncologist · doi:10.1634/theoncologist.9-6-633 · Cited by 239
The Warburg hypothesis fifty years later
Weinhouse, S. (1976) · Zeitschrift f�r Krebsforschung und Klinische Onkologie · doi:10.1007/bf00284370 · Cited by 228
Lonidamine, a selective inhibitor of aerobic glycolysis of murine tumor cells.
Floridi, A., Paggi, M. G., Marcante, M. L., Silvestrini, B., Caputo, A., & Martino, C. D. (1981) · PubMed · Cited by 211
Dowling, M. L., Voong, K. R., Kim, M., Keutmann, M. K., Harris, E., & Kao, G. D. (2005) · Cancer Biology & Therapy · doi:10.4161/cbt.4.2.1441 · Cited by 204
Effect of lonidamine on the energy metabolism of Ehrlich ascites tumor cells.
Floridi, A., Paggi, M. G., D’Atri, S., De Martino, C., Marcante, M. L., Silvestrini, B., & Caputo, A. (1981) · PubMed · Cited by 202
Newell, K., Franchi, A., Pouysségur, J., & Tannock, I. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.3.1127 · Cited by 197
KOYA, K., Li, Y., Wang, H., Ukai, T., Tatsuta, N., Kawakami, M., Shishido, & Chen, L. B. (1996) · PubMed · Cited by 181
Superoxide anion: Oncogenic reactive oxygen species?
Pervaiz, S., & Clement, M.-V. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.04.007 · Cited by 171
Self-citationBcl-2 induces pro-oxidant state by engaging mitochondrial respiration in tumor cells
Chen, Z. X., & Pervaiz, S. (2007) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402165 · Cited by 170
Self-citationPaclitaxel, cisplatin and lonidamine in advanced ovarian cancer. A phase II study
De Lena, M., Lorusso, V., Latorre, A., Fanizza, G., Gargano, G., Caporusso, L., Guida, M., Catino, A., Crucitta, E., Sambiasi, D., et al. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(00)00400-7 · Cited by 168
AIF-Mediated Programmed Necrosis: A Highly Orchestrated Way to Die
Boujrad, H., Gubkina, O., Robert, N., Krantic, S., & Susin, S. A. (2007) · Cell Cycle · doi:10.4161/cc.6.21.4842 · Cited by 165
Reactive oxygen intermediates regulate cellular response to apoptotic stimuli: An hypothesis
Clément, M.-V., & Pervaiz, S. (1999) · Free Radical Research · doi:10.1080/10715769900300271 · Cited by 159
Self-citationShi, Y., Chen, J., Weng, C., Chen, R., Zheng, Y., Chen, Q., & Tang, H. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00871-4 · Cited by 158
DNA-damaging reagents induce apoptosis through reactive oxygen species-dependent Fas aggregation
Huang, H.-L., Fang, L., Lu, S.-P., Chou, C., Luh, T., & Lai, M. (2003) · Oncogene · doi:10.1038/sj.onc.1206979 · Cited by 156
Cuezva, J. M., Chen, G., Alonso, A. M., Isidoro, A., Misek, D. E., Hanash, S. M., & Beer, D. G. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh113 · Cited by 155
Dobson, A. W., Xu, Y., Kelley, M. R., LeDoux, S. P., & Wilson, G. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000831200 · Cited by 143
Manero, F., Gautier, F., Gallenne, T., Cauquil, N., Gree, D. M., Cartron, P., Geneste, O., Gree, R. L., Vallette, F. M., & Juin, P. P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2097 · Cited by 135
Máximo, V., & Sobrinho-Simões, M. A. (2000) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s004280000219 · Cited by 129
Ahmad, K. A., Iskandar, K. B., Hirpara, J. L., Clement, M., & Pervaiz, S. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0648 · Cited by 129
Self-citationRaghunand, N., Martı́nez–Zaguilán, R., Wright, S. H., & Gillies, R. J. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00021-0 · Cited by 127
Tumor Intracellular Redox Status and Drug Resistance-Serendipity or a Causal Relationship?
Pervaiz, S., & Clement, M. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043384411 · Cited by 127
Self-citationBauer, J. A., Trask, D. K., Kumar, B., Los, G., Castro, J., Lee, J. J., Chen, J., Wang, S., Bradford, C. R., & Carey, T. E. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0081 · Cited by 124
Azarashvili, T., Grachev, D., Krestinina, O. V., Evtodienko, Y. V., Yurkov, I. S., Papadopoulos, V., & Reiser, G. (2006) · Cell Calcium · doi:10.1016/j.ceca.2006.11.004 · Cited by 118
Cytoplasmic p53: Bax and Forward
Chipuk, J. E., & Green, D. R. (2004) · Cell Cycle · doi:10.4161/cc.3.4.821 · Cited by 118
Targeting Apoptotic Pathways in Cancer Cells
Denicourt, C., & Dowdy, S. F. (2004) · Science · doi:10.1126/science.1102974 · Cited by 114
The unpredictable caspase-2: what can it do?
Vakifahmetoglu-Norberg, H., & Zhivotovsky, B. (2010) · Trends in Cell Biology · doi:10.1016/j.tcb.2009.12.006 · Cited by 114
Izeradjene, K., Douglas, L., Tillman, D. M., Delaney, A. B., & Houghton, J. A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2628 · Cited by 109
Xu, L., Yang, D., Wang, S., Tang, W., Liu, M., Davis, M. A., Chen, J., Rae, J. M., Lawrence, T. S., & Lippman, M. E. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.197.4.2 · Cited by 109
The Arf/p53 pathway in cancer and aging
Matheu, A., Maraver, A., & Serrano, M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6851 · Cited by 105
Shangary, S. K., & Johnson, D. E. (2002) · Biochemistry · doi:10.1021/bi025605h · Cited by 100
Schuyer, M., van der Burg, M. E. L., Henzen-Logmans, S. C., Fieret, J. H., Klijn, J. G. M., Look, M. P., Foekens, J. A., Stoter, G., & Berns, E. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.2101 · Cited by 95
Apoptosis: Silencing the death receptors
Tschopp, J., Martinon, F., & Hofmann, K. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80233-4 · Cited by 92
Measurement of Membrane Permeability and the Permeability Transition of Mitochondria
Zamzami, N., Maisse, C., Métivier, D., & Kroemer, G. (2007) · Methods in cell biology · doi:10.1016/s0091-679x(06)80016-6 · Cited by 91
Superoxide anion inhibits drug‐induced tumor cell death
Pervaiz, S., Ramalingam, J. K., Hirpara, J. L., & Clement, M. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01258-2 · Cited by 91
Self-citationPrognostic Impact of Bim, Puma, and Noxa Expression in Human Colon Carcinomas
Sinicrope, F. A., Rego, R. L., Okumura, K., Foster, N. R., O’Connell, M. J., Sargent, D. J., & Windschitl, H. E. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-5202 · Cited by 91
Adenine nucleotide translocase family: four isoforms for apoptosis modulation in cancer
Brenner, C., Subramaniam, K., Pertuiset, C., & Pervaiz, S. (2010) · Oncogene · doi:10.1038/onc.2010.501 · Cited by 90
Self-citationTherapeutic Exploitation of Checkpoint Defects in Cancer Cells Lacking p53 Function
Dixon, H., & Norbury, C. J. (2002) · Cell Cycle · doi:10.4161/cc.1.6.257 · Cited by 85
Pellecchia, M., & Reed, J. C. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043384880 · Cited by 83
Akram, S., Teong, H. F. C., Fliegel, L., Pervaiz, S., & Clément, M.-V. (2005) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401775 · Cited by 83
Self-citationShenoy, K., Wu, Y., & Pervaiz, S. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-1996 · Cited by 77
Self-citationHopkins-Donaldson, S., Cathomas, R. L., Simões‐Wüst, A. P., Kurtz, S., Belyanskya, L., Stahel, R. A., & Zangemeister‐Wittke, U. (2003) · International Journal of Cancer · doi:10.1002/ijc.11209 · Cited by 73
Lee, Y. J., Lee, K. H., Kim, H.-R. C., Jessup, J. M., Seol, D., Kim, T., Billiar, T. R., & Song, Y. K. (2001) · Oncogene · doi:10.1038/sj.onc.1204225 · Cited by 72
Katabi, M. M., Chan, H. L. B., Karp, S. E., et al. (1999) · Human Gene Therapy · doi:10.1089/10430349950018959 · Cited by 71
Expression of oxidative phosphorylation genes in renal tumors and tumoral cell lines
Faure, H., Heddi, A., Giraud, S., Chautard, D., & Stepien, G. (1996) · Molecular Carcinogenesis · Cited by 70
Vyssokikh, M. Y., Zorova, L. D., Zorov, D. B., Heimlich, G., Jürgensmeier, J. M., & Brdiczka, D. G. (2002) · Molecular Biology Reports · doi:10.1023/a:1020383108620 · Cited by 65
Chapter 8 Measurement of membrane permeability and permeability transition of mitochondria
Zamzami, N., Maisse, C., Métivier, D., & Kroemer, G. (2001) · Methods in cell biology · doi:10.1016/s0091-679x(01)65009-x · Cited by 63
Yamanaka, K., Rocchi, P., Miyake, H., Fazli, L., So, A., Zangemeister‐Wittke, U., & Gleave, M. E. (2006) · British Journal of Urology · doi:10.1111/j.1464-410x.2006.06147.x · Cited by 63
Alvero, A. B., Montagna, M. K., Chen, R., Kim, K. H., Kyungjin, K., Visintin, I., Fu, H., Brown, D., & Mor, G. (2009) · Cancer · doi:10.1002/cncr.24397 · Cited by 55
Woo, S. H., Park, I., Park, M., An, S., Lee, H.-C., Jin, H., Park, S., Cho, H., Lee, S., Gwak, H., et al. (2004) · International Journal of Cancer · doi:10.1002/ijc.20433 · Cited by 51
IAP proteins: sticking it to Smac
Duckett, C. S. (2004) · Biochemical Journal · doi:10.1042/bj20041800 · Cited by 51
Machida, K., Hayashi, Y., & Osada, H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204564200 · Cited by 46
Hong, S., Pusapati, R. V., Powers, J. T., & Johnson, D. G. (2006) · Cell Cycle · doi:10.4161/cc.5.8.2638 · Cited by 44
Poh, T. W., Huang, S., Hirpara, J. L., & Pervaiz, S. (2007) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402177 · Cited by 42
Self-citationHA14-1, a small molecule inhibitor of Bcl-2, bypasses chemoresistance in leukaemia cells
Oliver, L., Mahé, B., Gree, R. L., Vallette, F. M., & Juin, P. P. (2007) · Leukemia Research · doi:10.1016/j.leukres.2006.11.010 · Cited by 37
Jeong, S. H., Lee, H. W., Han, J. H., Kang, S. Y., Choi, J., Jung, Y. M., Choi, H. S., Oh, Y., Park, K. J., Hwang, S. C., et al. (2008) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyn089 · Cited by 36
Indran, I. R., Hande, M. P., & Pervaiz, S. (2009) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2009.12.001 · Cited by 33
Self-citationModica-Napolitano, J. S., Nalbandian, R., Kidd, M. E., Nalbandian, A., & Nguyen, C. C. (2003) · Cancer Letters · doi:10.1016/s0304-3835(03)00274-x · Cited by 30
Phase III trial with and without lonidamine in non-small cell lung cancer.
Gatzemeier, U., Cavalli, F., Häussinger, K., Kaukel, E., Koschel, G., Martinelli, G., Neuhauss, R., & von Pawel, J. (1991) · PubMed · Cited by 29
Oxidative repression of NHE1 gene expression involves iron-mediated caspase activity
Kumar, A. P., Chang, M. K. X., Fliegel, L., Pervaiz, S., & Clément, M.-V. (2007) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402176 · Cited by 27
Self-citationUwagawa, T., Misawa, T., Iida, T., Sakamoto, T., Gocho, T., Wakiyama, S., Hirohara, S., & Yanaga, K. K. (2010) · Journal of Palliative Medicine · doi:10.1089/jpm.2009.0404 · Cited by 14
Cited by
Flavonoids in Cancer and Apoptosis
Abotaleb, M., Samuel, S., Varghese, E., Varghese, S., Kubatka, P., Liskova, A., & Büsselberg, D. (2018) · Cancers · doi:10.3390/cancers11010028 · Cited by 751
The multi-factorial nature of clinical multidrug resistance in cancer
Assaraf, Y. G., Brozovic, A., Gonçalves, A. C., Jurkovicova, D., Linē, A., Machuqueiro, M., Saponara, S., Sarmento-Ribeiro, A. B., Xavier, C. P. R., & Vasconcelos, M. H. (2019) · Drug Resistance Updates · doi:10.1016/j.drup.2019.100645 · Cited by 528
Getting TRAIL back on track for cancer therapy
Lemke, J., von Karstedt, S., Zinngrebe, J., & Walczak, H. (2014) · Cell Death & Differentiation · doi:10.1038/cdd.2014.81 · Cited by 457
Challenges and Opportunities in Cancer Drug Resistance
Ward, R. A., Fawell, S., Floc’h, N., Flemington, V., McKerrecher, D., & Smith, P. D. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00383 · Cited by 445
Bisphenol A (BPA) and cell signaling pathways
Murata, M., & Kang, J.-H. (2018) · Biotechnology Advances · doi:10.1016/j.biotechadv.2017.12.002 · Cited by 361
Metadata
- Authors
- Indran, I. R., Tufo, G., Pervaiz, S., & Brenner, C.
- Venue
- Biochimica et Biophysica Acta (BBA) - Bioenergetics
- Publisher
- Elsevier BV
- Published
- 2011-06
- Volume
- 1807
- Issue
- 6
- Pages
- 735-745
- ISSN
- 0005-2728 (ISSN-L)
- OpenAlex
- W2060003051
- Cited by
- 526
- References
- 140
- FWCI
- 11.05
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.